Why the study?
Although cardiopulmonary exercise testing is the gold standard for exercise capacity evaluation in heart failure, the value, clinical usefulness, and limitations of the submaximal 6-minute walking test warrant summarization.
Does the 6-minute walking test provide reliable information about functional status and prognosis in patients with heart failure?
Does the 6-minute walking test provide reliable information about functional status and prognosis in patients with heart failure?
Answers are grounded in this paper and cite their sources.
The 6-minute walking test serves as a practical, widely available tool for evaluating functional capacity and prognosis in heart failure patients.
Reduced functional ability and exercise tolerance in patients with heart failure (HF) are associated with poor quality of life and a worse prognosis. The 6-minute walking test (6MWT) is a widely available and well-tolerated test for the assessment of the functional capacity of patients with HF. Although the cardiopulmonary exercise test (a maximal exercise test) remains the gold standard for the evaluation of exercise capacity in patients with HF, the 6MWT (submaximal exercise test) may provide reliable information about the patient's daily activity. The current review summarizes the value of 6MWT in patients with HF and identifies its usefulness and limitations in everyday clinical practice in populations of HF. We aimed to investigate potential associations of 6MWD with other measures of functional status and determinants of 6MWD in patients with HF as well as to review its prognostic role and changes to various interventions in these patients.
No takes yet. Share an insight, caveat, or question.
Giannitsi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: